+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Sterile Injectables Market - Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023

  • ID: 4771585
  • Report
  • Region: Global
  • Azoth Analytics
1 of 4

FEATURED COMPANIES

  • Astra Zeneca
  • Baxer International
  • Gilead Sciences
  • Glaxo smith kline
  • Merck & Co.
  • Novartis
  • MORE

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Sterile Injectables Market by Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders -Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce). The report assess the global market, the regional markets (APAC , North America, Europe, ROW) and country analysis (United States, Canada, United Kingdom, Germany, China, India, Japan, Brazil, Saudi Arabia).

According to the research report the global market is projected to display a robust growth represented by a CAGR of 6.39 % during 2018-2023.

Growth of the global sterile injectables market is primarily driven by increasing prevalence of chronic diseases and rapidly increasing ageing population that are highly susceptible to chronic diseases. Moreover, rise in the global healthcare expenditure, changing lifestyle and rising demand for the better quality of life are some of the macro economic factors which impelled the growth of the market.

The report titled “Global Sterile Injectables Market-Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type (Biologic, Small Molecule), Drug Type (Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin), Indication (Disorders -Oncological, Cardiovascular, Neurological, Infectious, Metabolic, Musculoskeletal), Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)” has covered and analysed the potential of Global Sterile Injectables Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global sterile injectables. Additionally, the report also highlights market entry dynamics for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Sterile Injectables Market -Sizing, Growth, Forecast
  • Molecule Type - Biologic, Small Molecule
  • Drug Type - Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin
  • Indication (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders)
  • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)

Regional Markets -North America, Europe, APAC and Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Sterile Injectables Market -Sizing, Growth, Forecast
  • Molecule Type - Biologic, Small Molecule
  • Drug Type - Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin
  • Indication (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders)
  • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)

Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Sterile Injectables Market -Sizing, Growth, Forecast
  • Molecule Type - Biologic, Small Molecule
  • Drug Type - Monoclonal Antibody, Insulin, Vaccine, Fusion Protein, Immunoglobulin
  • Indication (Oncological Disorders, Cardiovascular Disorders, Neurological Disorders, Infectious Disorders, Metabolic Disorders, Musculoskeletal Disorders)
  • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-commerce)

Other Report Highlights

  • Market Dynamics -Drivers and Restraints
  • Market Trends
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Company Analysis -Sanofi, Pfizer, Baxer International, Glaxo smith kline, Novartis, Gilead Sciences, Merck & Co., Astra Zeneca

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Astra Zeneca
  • Baxer International
  • Gilead Sciences
  • Glaxo smith kline
  • Merck & Co.
  • Novartis
  • MORE

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Sterile Injectables Outlook

5. Global Sterile Injectables: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Sterile Injectables Market – Segment Analysis
6.1 Global Sterile Injectables Market – By Molecule Type
6.1.1 By Type, 2017 (%)
6.1.2 By Type, 2023 (%)
6.2 Global Biologic Sterile Injectables Market, By Value (2013-2023)
6.3 Global Small Molecule Sterile Injectables Market, By Value (2013-2023)

6.4 Global Sterile Injectables Market – By Biologic Drug Type
6.4.1 By Type, 2017 (%)
6.4.2 By Type, 2023 (%)
6.5 Global Monoclonal Antibody Sterile Injectables Market, By Value (2013-2023)
6.6 Global Insulin Sterile Injectables Market, By Value (2013-2023)
6.7 Global Vaccines Sterile Injectables Market, By Value (2013-2023)
6.8 Global Fusion Proteins Sterile Injectables Market, By Value (2013-2023)
6.9 Global Immunoglobulins Sterile Injectables Market, By Value (2013-2023)
6.10 Global Others Biologic Sterile Injectables Market, By Value (2013-2023)

6.11 Global Sterile Injectables Market – By Indication
6.11.1 By Indication, 2017 (%)
6.11.2 By Indication, 2023 (%)
6.12 Global Sterile Injectables For Oncological Disorders Market, By Value (2013-2023)
6.13 Global Sterile Injectables For Infectious Disorders Market, By Value (2013-2023)
6.14 Global Sterile Injectables For Metabolic Disorders Market, By Value (2013-2023)
6.15 Global Sterile Injectables For Cardiovascular Disorders Market, By Value (2013-2023)
6.16 Global Sterile Injectables For Neurological Disorders Market, By Value (2013-2023)
6.17 Global Sterile Injectables For Musculoskeletal Disorders Market, By Value (2013-2023)
6.18 Global Others Indication Sterile Injectables Market, By Value (2013-2023)

6.19 Global Sterile Injectables Market – By Distribution Channel
6.19.1 By Distribution Channel, By Value, 2017 (%)
6.19.2 By Distribution Channel, By Value, 2023 (%)
6.20 Global Hospital Pharmacy Sterile Injectables Market, By Value (2013-2023)
6.21 Global Retail Pharmacy Sterile Injectables Market, By Value (2013-2023)
6.22 Global Ecommerce Sterile Injectables Market, By Value (2013-2023)

7. Global Sterile Injectables Market: Regional Analysis
7.1 Global Sterile Injectables Market Size, By Region: Breakdown (%)
7.1.1 By Region, By Value, 2017 (%)
7.1.2 By Region, By Value, 2023 (%)

7.2 North America Sterile Injectables Market: An Analysis
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.2.3 By Molecule Type, By Value (2013-2023)
7.2.4 By Biologic Drug Type, By Value (2013-2023)
7.2.5 By Indication, By Value (2013-2023)
7.2.6 By Distribution Channel, By Value (2013-2023)

7.3 North America Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.3.1 U.S Sterile Injectables Market, By Value (2013-2023)
7.3.2 U.S Sterile Injectables Market, By Indication, By Value (2013-2023)
7.3.3 Canada Sterile Injectables Market, By Value (2013-2023)
7.3.4 Canada Sterile Injectables Market, By Indication, By Value (2013-2023)

7.4 Europe Sterile Injectables Market: An Analysis
7.4.1 By Value (2013-2017)
7.4.2 By Value (2018-2023)
7.4.3 By Molecule Type, By Value (2013-2023)
7.4.4 By Biologic Drug Type, By Value (2013-2023)
7.4.5 By Indication, By Value (2013-2023)
7.4.6 By Distribution Channel, By Value (2013-2023)

7.5 Europe Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.5.1 Germany Sterile Injectables Market, By Value (2013-2023)
7.5.2 Germany Sterile Injectables Market, By Indication, By Value (2013-2023)
7.5.3 United Kingdom Sterile Injectables Market, By Value (2013-2023)
7.5.4 United Kingdom Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Rest of Europe Sterile Injectables Market, By Value (2013-2023)

7.6 APAC Sterile Injectables Market: An Analysis
7.6.1 By Value (2013-2017)
7.6.2 By Value (2018-2023)
7.6.3 By Molecule Type, By Value (2013-2023)
7.6.4 By Biologic Drug Type, By Value (2013-2023)
7.6.5 By Indication, By Value (2013-2023)
7.6.6 By Distribution Channel, By Value (2013-2023)

7.7 APAC Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.7.1 China Sterile Injectables Market, By Value (2013-2023)
7.7.2 China Sterile Injectables Market, By Indication, By Value (2013-2023)
7.7.3 Japan Sterile Injectables Market, By Value (2013-2023)
7.7.4 Japan Injectables Market, By Indication, By Value (2013-2023)
7.7.5 India Sterile Injectables Market, By Value (2013-2023)
7.7.6 India Injectables Market, By Indication, By Value (2013-2023)
7.7.7 Rest of APAC Sterile Injectables Market, By Value (2013-2023)

7.8 Rest of the World Sterile Injectables Market: An Analysis
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.8.3 By Molecule Type, By Value (2013-2023)
7.8.4 By Biologic Drug Type, By Value (2013-2023)
7.8.5 By Distribution Channel, By Value (2013-2023)

7.9 Rest of the World Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
7.9.1 Brazil Sterile Injectables Market, By Value (2013-2023)
7.9.2 Brazil Sterile Injectables Market, By Indication, By Value (2013-2023)
7.9.3 Saudi Arabia Sterile Injectables Market, By Value (2013-2023)
7.5.4 Saudi Arabia Injectables Market, By Indication, By Value (2013-2023)
7.5.5 Other Sterile Injectables Market, By Value (2013-2023)

8. Global Sterile Injectables Market Dynamics
8.1 Global Sterile Injectables Market Drivers
8.2 Global Sterile Injectables Market Restraints

9. Global Sterile Injectables Market Trends

10. Policy and Regulatory Landscape

11. Porter Five Force Analysis

12. SWOT Analysis

13. Company Profiles
13.1 Sanofi
13.2 Pfizer
13.3 Baxer International
13.4 Glaxosmithkline
13.5 Novartis
13.6 Gilead Sciences
13.7 Merck & Co.
13.8 Astra Zeneca

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Sanofi
  • Pfizer
  • Baxer International
  • Glaxo smith kline
  • Novartis
  • Gilead Sciences
  • Merck & Co.
  • Astra Zeneca
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll